These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2131 related articles for article (PubMed ID: 32895551)

  • 1. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
    Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
    Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
    Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
    Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses.
    Liu M; Chen M; Tan J; Chen A; Guo J
    Arch Dermatol Res; 2024 Jul; 316(7):443. PubMed ID: 38951247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the causal effect of circulating proteome on the risk of inflammatory bowel disease-related traits using Mendelian randomization.
    Li B; Hu P; Liang H; Zhao X; Zhang A; Xu Y; Zhang B; Zhang J
    Front Immunol; 2024; 15():1434369. PubMed ID: 39144148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study.
    Zhao H; Zhou Y; Wang Z; Zhang X; Chen L; Hong Z
    Front Immunol; 2024; 15():1417564. PubMed ID: 39026678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
    Li J; Ma X; Yin C
    Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.
    Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ
    Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
    Zou M; Shao Z
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian Randomization and Bayesian Colocalization Analysis Implicate Glycoprotein VI as a Potential Drug Target for Cardioembolic Stroke in South Asian Populations.
    Wu S; Meena D; Yarmolinsky J; Gill D; Smith A; Dib MJ; Chauhan G; Rohatgi A; Dehghan A; Tzoulaki I
    J Am Heart Assoc; 2024 Aug; 13(16):e035008. PubMed ID: 39119976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-centric omics integration analysis identifies candidate plasma proteins for multiple autoimmune diseases.
    Chen Y; Liu S; Gong W; Guo P; Xue F; Zhou X; Wang S; Yuan Z
    Hum Genet; 2024 Oct; 143(9-10):1035-1048. PubMed ID: 38143258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.
    Bourgault J; Abner E; Manikpurage HD; Pujol-Gualdo N; Laisk T; ; Gobeil É; Gagnon E; Girard A; Mitchell PL; Thériault S; Esko T; Mathieu P; Arsenault BJ
    Gastroenterology; 2023 May; 164(6):953-965.e3. PubMed ID: 36736436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
    Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
    EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome-wide Mendelian randomization identified potential drug targets for migraine.
    Xiong Z; Zhao L; Mei Y; Qiu D; Li X; Zhang P; Zhang M; Cao J; Wang Y
    J Headache Pain; 2024 Sep; 25(1):148. PubMed ID: 39261750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study.
    Cai YX; Wu YQ; Liu J; Pan H; Deng W; Sun W; Xie C; Huang XF
    BMC Cancer; 2023 Dec; 23(1):1188. PubMed ID: 38049731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening.
    You W; Lin Y; Liu M; Lin Z; Ye R; Zhang C; Zeng R
    Front Immunol; 2024; 15():1406041. PubMed ID: 39185422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
    Zhang Y; Liu W; Lai J; Zeng H
    Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
    Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
    Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pinpointing Novel Plasma and Brain Proteins for Common Ocular Diseases: A Comprehensive Cross-Omics Integration Analysis.
    Mo Q; Liu X; Gong W; Wang Y; Yuan Z; Sun X; Wang S
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
    Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
    J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 107.